Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins. - Wikidata - wikimedia - TriplyDB

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.

http://www.wikidata.org/entity/Q39421660

about

PLA2G7 associates with hormone receptor negativity in clinical breast cancer samples and regulates epithelial-mesenchymal transition in cultured breast cancer cells Suppression of interactions between prostate tumor cell-surface integrin and endothelial ICAM-1 by simvastatin inhibits micrometastasis Serum levels of arachidonic acid metabolites change during prostate cancer progression.Expression of ERG protein in prostate cancer: variability and biological correlates.The broad-spectrum anti-DNA virus agent cidofovir inhibits lung metastasis of virus-independent, FGF2-driven tumors.Differentially Expressed Genes and Signature Pathways of Human Prostate Cancer.Multivariate models from RNA-Seq SNVs yield candidate molecular targets for biomarker discovery: SNV-DA Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies.Tuberous sclerosis complex 2 loss increases lysophosphatidylcholine synthesis in lymphangioleiomyomatosis.Repression of endometrial tumor growth by targeting SREBP1 and lipogenesis Statin use and breast cancer survival: a nationwide cohort study in Scotland.Aggressive rat prostate tumors reprogram the benign parts of the prostate and regional lymph nodes prior to metastasis.Repositioning antipsychotic chlorpromazine for treating colorectal cancer by inhibiting sirtuin 1 Selective inhibitors and tailored activity probes for lipoprotein-associated phospholipase A(2)Deficiency of phospholipase A2 group 7 decreases intestinal polyposis and colon tumorigenesis in Apc(Min/+) mice.Association of six CpG-SNPs in the inflammation-related genes with coronary heart disease Monocyte-derived factors including PLA2G7 induced by macrophage-nasopharyngeal carcinoma cell interaction promote tumor cell invasiveness.Current challenges in development of differentially expressed and prognostic prostate cancer biomarkers.Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells.Drug discovery in advanced prostate cancer: translating biology into therapy.Downregulation of sorting nexin 10 is associated with overexpression of miR-30d during liver cancer progression in rats.Effect of statins type on incident prostate cancer risk: a meta-analysis and systematic review.Tumorigenic potential of circulating prostate tumor cells.Emergence of ETS transcription factors as diagnostic tools and therapeutic targets in prostate cancer.Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation.High lysophosphatidylcholine acyltransferase 1 expression independently predicts high risk for biochemical recurrence in prostate cancers.Study of NGEP expression pattern in cancerous tissues provides novel insights into prognostic marker in prostate cancer.miR-301a expression: A prognostic marker for prostate cancer.Reduced expression of NGEP is associated with high-grade prostate cancers: a tissue microarray analysis.Diagnostic marker signature for esophageal cancer from transcriptome analysis.Enzalutamide and CXCR7 inhibitor combination treatment suppresses cell growth and angiogenic signaling in castration-resistant prostate cancer models.Guzhi Zengsheng Zhitongwan, a Traditional Chinese Medicinal Formulation, Stimulates Chondrocyte Proliferation through Control of Multiple Genes Involved in Chondrocyte Proliferation and Differentiation

P2860

Q33593900-03B698F7-48F4-4ACD-A720-DF1E11214030 Q33684159-B2EBDDF4-02B0-4060-8EE0-81455A1D6B8A Q34398467-E964E186-7A13-49E8-AA7B-5DA78FAD0A51 Q35608000-829DEF2A-6232-4277-867F-DC44F240208F Q35741522-668C67BD-4DF1-459B-B145-EF55B307F04E Q35873154-839E8B36-D004-4AC4-9086-912B29EEF711 Q35974524-4FF9EFCA-D7C5-4BF2-89FD-077D7A102F2D Q36022437-80E3D7E5-E7F7-4A53-A2BF-6FBF454AF8A5 Q36049513-8D708DAB-AA09-463F-B9D1-8066BECEA531 Q36059708-458AC696-F849-429E-8B53-46FD89B6DB0B Q36095264-C5801EE1-F5AD-429D-A59A-6EBE65BD4F4F Q36363019-8B3625EE-A21F-46A4-9A4C-397EC1C46318 Q36413835-E0BD552B-D8D9-4BD3-8FB0-1A7C38EFC7DA Q36547608-9F674EA8-C6AB-457B-8D68-A4CC253333AA Q36815195-7B9D056D-BD59-4B38-A309-19016335235E Q37137160-D65B7D5B-24A8-4F02-AF01-88CC3D544A6F Q37688255-46262D31-B7DE-4545-ABB0-F64DD2135E96 Q38042634-04DB38CF-CBC3-4EF8-95FC-7021C8CBFD54 Q38311168-E03190B9-3946-4B1F-AC28-4E96D00C5E09 Q38839110-390DB470-FDD0-4803-B04D-413A3ECDC64D Q38851888-74BB17AB-095D-4AF4-BC22-69A75BAEBA31 Q39031198-E0C75201-67A6-49B0-9B0F-C7940C225213 Q39175526-49170F49-6F4A-41A0-BD0C-5421BC107FEF Q40028950-2868C973-8037-4E3B-A4E9-758F2559766E Q40052310-A7A34359-3C0B-4A19-92FD-C6433A89133D Q41134388-D302B810-47BD-46E5-ABCC-DB7AD5299710 Q41161352-D7327893-B8C1-47ED-9EDD-B5F56D7DDBDE Q42391915-CEE0B5F4-2949-4554-93B0-8C02A91DEFFF Q43725536-0ACB36F8-5ED2-4AB9-9D13-730B381A5804 Q48095123-3F61465B-1E9F-4846-A4F7-FB13560826B5 Q48349923-0D032034-8CF5-4D03-9042-F03143761892 Q57112342-A7F47136-14D3-4FFD-9DB3-3D53154C935B

P2860

Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.

http://www.wikidata.org/entity/Q39421660

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年学术文章

@wuu

2011年学术文章

@zh-cn

2011年学术文章

@zh-hans

2011年学术文章

@zh-my

2011年学术文章

@zh-sg

2011年學術文章

@yue

2011年學術文章

@zh

2011年學術文章

@zh-hant

name

Phospholipase PLA2G7, associat ...... n and is inhibited by statins.

@en

Phospholipase PLA2G7, associat ...... n and is inhibited by statins.

@nl

type

label

Phospholipase PLA2G7, associat ...... n and is inhibited by statins.

@en

Phospholipase PLA2G7, associat ...... n and is inhibited by statins.

@nl

prefLabel

Phospholipase PLA2G7, associat ...... n and is inhibited by statins.

@en

Phospholipase PLA2G7, associat ...... n and is inhibited by statins.

@nl

P1433

Q39421660-5BA06EFF-D29C-48AB-AECC-375ABAC4651D

P1476

Q39421660-CF6B7D07-D338-492A-9819-5C029791B9AF

P2093

Q39421660-0AED396C-A340-4ACB-B3DD-3B9CB91055E4

Q39421660-468BEFDC-2CDE-459F-AAAC-864B3B8805A3

Q39421660-62736828-3655-411B-AF21-2C8709003472

Q39421660-62B211B7-2BB8-4B9C-9184-9E1345612F41

Q39421660-8FC95C8D-74BE-47B9-B098-CA5903906337

Q39421660-A92DE412-40FC-437E-B8E2-9E63DF377674

Q39421660-ABC17A73-8FE3-4FB4-B085-9FBD92FB0E8E

Q39421660-B15273B8-F266-44E8-AF2A-74922E61D3C4

Q39421660-D4B02BB6-836A-4D47-834F-0D9C30973EEC

Q39421660-E6544DDF-5A77-413C-90D8-69A0B1585447

P2860

Q39421660-066A5022-6381-4809-AE53-3166E2577D39

Q39421660-10497F5F-6C32-4B17-A77E-04B35C706FD3

Q39421660-143AC30F-9CE1-44D3-AA47-061730708D9A

Q39421660-193C050F-FCF7-488C-A9D3-1450AD182B0F

Q39421660-19B90436-43F1-41C5-AD11-654677163B91

Q39421660-1C89D8B7-8F47-4B27-A361-AC3A9F405B95

Q39421660-218634E6-CBC6-40E7-96F0-819C5BEF7FE9

Q39421660-2CB69D53-3902-43F9-9BBB-B7C186AFE056

Q39421660-3848AC39-1596-481E-9BAB-991887E084E3

Q39421660-40C2451A-EA15-493F-AF65-12EE493DF8F1

P304

Q39421660-6AE74573-7698-4697-9C59-35E3757A6DF7

P31

Q39421660-E55FBFE3-6229-4EF8-8FF8-AC943B02AEC2

P356

Q39421660-3CE33040-C54B-41D1-B754-5E161EA4CC1E

P407

Q39421660-6EB60807-24FD-4E87-938B-60EEF9CD824E

P433

Q39421660-5C19AD0B-293F-4E7A-9CE5-E0B0E7858D41

P478

Q39421660-5B89383E-2976-4B11-AF57-C55447EBC8A7

P50

Q39421660-4C55EF3A-BC18-46DA-96EE-7B7EB9A65C37

Q39421660-CF6D5647-CA9B-427D-9544-6603729F4AF1

Q39421660-D998ABBA-C7AF-4B5D-9DC1-EF8DB6DB6763

P577

Q39421660-3100BDA8-7EA8-4CEE-A649-C99710E75E73

P5875

Q39421660-FEF162FF-6441-49DD-BC13-DDBE15179BD6

P698

Q39421660-8779B4E8-50CF-4E59-9F4F-1767A1854187

P932

Q39421660-0BAEA045-4E3A-441E-9250-154FEEE9D008

P356

P1433

P1476

Phospholipase PLA2G7, associat ...... on and is inhibited by statins

@en

P2093

Anna Sankila

http://www.w3.org/2001/XMLSchema#string

Antti Rannikko

http://www.w3.org/2001/XMLSchema#string

Johannes Virtanen

http://www.w3.org/2001/XMLSchema#string

Kristiina Iljin

http://www.w3.org/2001/XMLSchema#string

Laura Lehtinen

http://www.w3.org/2001/XMLSchema#string

Matej Orešič

http://www.w3.org/2001/XMLSchema#string

Mika Hilvo

http://www.w3.org/2001/XMLSchema#string

Stig Nordling

http://www.w3.org/2001/XMLSchema#string

Tuomas Mirtti

http://www.w3.org/2001/XMLSchema#string

Tuulikki Seppänen-Laakso

http://www.w3.org/2001/XMLSchema#string

P2860

Bioconductor: open software development for computational biology and bioinformatics

Global cancer statistics

ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome

Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development

A comprehensive panel of three-dimensional models for studies of prostate cancer growth, invasion and drug responses

Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer.

Linear models and empirical bayes methods for assessing differential expression in microarray experiments

Role of the TMPRSS2-ERG gene fusion in prostate cancer

Rosuvastatin, identified from a zebrafish chemical genetic screen for antiangiogenic compounds, suppresses the growth of prostate cancer.

High aldehyde dehydrogenase activity identifies tumor-initiating and metastasis-initiating cells in human prostate cancer.

P304

1176-1190

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.397

http://www.w3.org/2001/XMLSchema#string

P407

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Olli-Pekka Kallioniemi

P577

2011-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51926177

http://www.w3.org/2001/XMLSchema#string

P698

22202492

http://www.w3.org/2001/XMLSchema#string

P932

3282076

http://www.w3.org/2001/XMLSchema#string